© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
May 25, 2021
A discussion on issues surrounding the treatment of HIV with Melissa Badowski, PharmD, MPH.
May 24, 2021
A conversation on antimicrobial stewardship with Kushal Naik, PharmD, MBA.
May 23, 2021
An investigational therapy demonstrated neutralizing antibodies as well as protection against the virus in preclinical trials.
A study looked at hospital admissions of Medicare patients and saw a large percentage of recurrent Clostridioides difficile infections (rCDI) as the primary diagnosis.
May 22, 2021
No difference was observed in any of the outcomes and there was no impact on the duration of therapy.
GDC and DSENS were both seen to be safe and effective tools to optimize therapy in the study participants.
May 21, 2021
An effort to increase stewardship showed that 5-day and 10-day prescription stop dates for antibiotics did little to influence actual therapy length and outcomes.
A diagnostic analyzer was studied looking at 3 biomarkers to predict the level of COVID-19, and could potentially serve as a risk stratification tool.
An assessment from the Cleveland Clinic shows prescribing concordant to guidelines can exceed 60% in certain facilities.
Almost half of the participants in the study had an opportunity to improve their antibiotic regimen.